Mannkind (MNKD) Depreciation & Amortization (CF) (2010 - 2026)

Mannkind (MNKD) reported Depreciation & Amortization (CF) of $6.4 million for Q1 2026, up 203.04% year-over-year from $2.1 million in Q1 2025, and up 5.84% quarter-over-quarter from $6.0 million in Q4 2025.

Mannkind (MNKD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $6.4 million in Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $6.4 million, up 203.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.6 million (up 104.04% YoY), and the FY2025 annual result was $12.3 million, up 66.65% from the prior year.
  • Depreciation & Amortization (CF) improved to $6.4 million in Q1 2026 per MNKD's latest filing, from $6.0 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $6.4 million in Q1 2026 and troughed at $599000.0 in Q1 2022.
  • A 5-year average of $2.0 million and a median of $1.4 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) slipped 28.44% in 2022, then soared 203.04% in 2026.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.0 million in 2022, then advanced by 20.45% to $1.2 million in 2023, then soared by 76.33% to $2.2 million in 2024, then soared by 179.17% to $6.0 million in 2025, then advanced by 5.84% to $6.4 million in 2026.
  • Business Quant data shows MNKD's Depreciation & Amortization (CF) at $6.4 million in Q1 2026, $6.0 million in Q4 2025, and $2.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 6.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.38 Mn
Mar 31, 2026 6.38 Mn
Dec 31, 2025 6.03 Mn
Dec 31, 2025 6.03 Mn
Sep 30, 2025 2.06 Mn
Sep 30, 2025 2.06 Mn
Jun 30, 2025 2.09 Mn
Jun 30, 2025 2.09 Mn
Mar 31, 2025 2.11 Mn
Mar 31, 2025 2.11 Mn
Dec 31, 2024 2.16 Mn
Dec 31, 2024 2.16 Mn
Sep 30, 2024 2.12 Mn
Sep 30, 2024 2.12 Mn
Jun 30, 2024 1.73 Mn
Jun 30, 2024 1.73 Mn
Mar 31, 2024 1.36 Mn
Mar 31, 2024 1.36 Mn
Dec 31, 2023 1.23 Mn
Dec 31, 2023 1.23 Mn